Highlights bioMérieux

Equities

BIM

FR0013280286

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris Other stock markets 16:55:00 09/07/2025 BST			After hours 18:57:06
119.70 ^EUR	+0.59%		120.05	+0.29%

06-16	BioMérieux S.A. acquired Key Assets of Day Zero Diagnostics Inc.	CI
06-16	BioMérieux: agreement to acquire Day Zero Diagnostic	CF

Highlights

BioMérieux S.A. acquired Key Assets of Day Zero Diagnostics Inc.	06-16	CI
BioMérieux: agreement to acquire Day Zero Diagnostic	06-16	CF
Biomerieux Acquires Day Zero Diagnostics Solutions And Technologies	06-16	RE
Ex-dividend day for final dividend	06-08	FA
BioMérieux S.A. Launches Equine Infectious Respiratory Disease Testing with VETFIRE	06-03	CI
GXO Logistics, Inc. Extends Long-Term Contract Renewal and Extension with BioMerieux	05-22	CI
BIOMÉRIEUX : RBC downgrades stock	05-07	CF
BIOMÉRIEUX : Invest Securities remains positive, cuts TP	04-22	CF
European shares clock marginal losses after ECB eases rates as expected	04-17	RE
BioMérieux: quarterly revenue up over 13%	04-17	CF
Biomerieux Q1 Total Sales EUR 1.10 Billion	04-17	RE
BioMérieux's Lumed Apss Software System Wins CE Marking	04-07	MT
Biomerieux Obtains CE-Marking For LUMED APSS	04-07	RE
BioMerieux Receives FDA 510(k) Clearance for its VITEK®? COMPACT PRO, a New ID/AST System to Fight Against Antimicrobial Resistance	03-18	CI
BioMérieux Gets US FDA Clearance for Microbial Identification Testing System	03-18	MT
Biomerieux Receives FDA Clearance For Its Vitek Compact Pro	03-18	RE
BioMérieux S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	03-07	CI
BIOMERIEUX : Q4 profitability exceeded expectations; however, the 2025 guidance is slightly below projections	03-07
BIOMÉRIEUX : Oddo BHF reiterates its recommendation on the share.	03-07	CF
Biomérieux S.A. Proposes Dividend for the Year 2024	03-07	CI
BioMérieux: Group net income of 432 ME in 2024	03-07	CF
Biomerieux FY Net Profit At EUR 432 Mln	03-07	RE
BioMerieux Receives Health Canada Approval for the BioFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel	02-25	CI
BioMérieux Launches GENE-UP® TYPER	02-13	CI
BioMérieux Receives US FDA Clearance for Updated Gastroenteritis Test	02-11	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

BIOMERIEUX : Remains an attractive investment and top choice in the testing sector

April 24, 2025 at 04:22 pm